• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮与心脏。

Aldosterone and the heart.

作者信息

Young M, Funder J W

机构信息

Baker Medical Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia.

出版信息

Trends Endocrinol Metab. 2000 Aug;11(6):224-6. doi: 10.1016/s1043-2760(00)00270-8.

DOI:10.1016/s1043-2760(00)00270-8
PMID:10878752
Abstract

Classically, aldosterone is a steroid hormone secreted from the adrenal cortex, which acts on kidney, colon and sweat/salivary glands to promote unidirectional sodium transport. Currently, there is excellent experimental evidence for aldosterone acting directly on the central nervous system to raise blood pressure, and on the heart to cause cardiac hypertrophy and fibrosis. In addition, there is emerging evidence for aldosterone synthesis in the heart, and for as yet unexplained benefits of aldosterone antagonism in the treatment of cardiac failure.

摘要

传统上,醛固酮是一种从肾上腺皮质分泌的类固醇激素,作用于肾脏、结肠以及汗腺/唾液腺,促进单向钠转运。目前,有充分的实验证据表明醛固酮可直接作用于中枢神经系统以升高血压,还可作用于心脏导致心肌肥厚和纤维化。此外,越来越多的证据表明心脏中存在醛固酮合成,且醛固酮拮抗剂在治疗心力衰竭方面有尚未得到解释的益处。

相似文献

1
Aldosterone and the heart.醛固酮与心脏。
Trends Endocrinol Metab. 2000 Aug;11(6):224-6. doi: 10.1016/s1043-2760(00)00270-8.
2
[Endocrinology of aldosterone].
Ital Heart J. 2005 May;6 Suppl 1:5S-15S.
3
Aldosterone and vascular damage.醛固酮与血管损伤。
Curr Hypertens Rep. 2000 Jun;2(3):327-34. doi: 10.1007/s11906-000-0017-z.
4
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.醛固酮驱动的心脏肥大和心力衰竭转基因模型。
Circ Res. 2003 Jul 11;93(1):69-76. doi: 10.1161/01.RES.0000080521.15238.E5. Epub 2003 Jun 5.
5
[Aldosterone--classic and non classic effects].
Harefuah. 2002 Jun;141(6):544-51, 578, 577.
6
Aldosterone receptor antagonism in heart failure.心力衰竭中的醛固酮受体拮抗作用。
Pharmacotherapy. 2005 Aug;25(8):1126-33. doi: 10.1592/phco.2005.25.8.1126.
7
Is aldosterone synthesized in the CNS regulated and functional?
Trends Endocrinol Metab. 2003 Dec;14(10):444-6. doi: 10.1016/j.tem.2003.10.004.
8
[Cardiac aldosterone].
Nihon Rinsho. 2006 May;64(5):837-42.
9
[Aldosterone and cardiovascular diseases, more than water and salt retention].[醛固酮与心血管疾病,不止于水盐潴留]
Verh K Acad Geneeskd Belg. 2002;64(3):225-32.
10
Why are mineralocorticoid receptor antagonists cardioprotective?盐皮质激素受体拮抗剂为何具有心脏保护作用?
Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec;374(3):153-62. doi: 10.1007/s00210-006-0107-9. Epub 2006 Oct 31.

引用本文的文献

1
Pharmacology and Therapeutic Potential of Finerenone: A Novel Third-Generation Nonsteroidal Mineralocorticoid Receptor Antagonist.非奈利酮的药理学及治疗潜力:一种新型第三代非甾体类盐皮质激素受体拮抗剂
Cureus. 2025 Jul 11;17(7):e87706. doi: 10.7759/cureus.87706. eCollection 2025 Jul.
2
Hyperhidrosis: the neglected sign in heart failure patients.多汗症:心力衰竭患者中被忽视的体征。
Am J Cardiovasc Dis. 2021 Oct 25;11(5):635-641. eCollection 2021.
3
Antiviral activity of the mineralocorticoid receptor NR3C2 against Herpes simplex virus Type 1 (HSV-1) infection.
矿物质皮质激素受体 NR3C2 抗单纯疱疹病毒 1 型(HSV-1)感染的抗病毒活性。
Sci Rep. 2018 Oct 26;8(1):15876. doi: 10.1038/s41598-018-34241-w.
4
Pharmacophore Modeling and Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.人细胞色素P450 11B1和细胞色素P450 11B2抑制剂的药效团建模与筛选
Front Chem. 2017 Dec 19;5:104. doi: 10.3389/fchem.2017.00104. eCollection 2017.
5
Corticosteroids Are Essential for Maintaining Cardiovascular Function in Male Mice.皮质类固醇对维持雄性小鼠的心血管功能至关重要。
Endocrinology. 2016 Jul;157(7):2759-71. doi: 10.1210/en.2015-1604. Epub 2016 May 24.
6
Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.利用噬菌体展示技术鉴定盐皮质激素受体的配体选择性肽拮抗剂。
Mol Endocrinol. 2011 Jan;25(1):32-43. doi: 10.1210/me.2010-0193. Epub 2010 Nov 24.
7
Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.心肌细胞中醛固酮受体信号的分子特征:从培养细胞到小鼠心脏。
Endocrinology. 2010 Sep;151(9):4467-76. doi: 10.1210/en.2010-0237. Epub 2010 Jun 30.
8
Central mineralocorticoid receptors and cardiovascular disease.中枢盐皮质激素受体与心血管疾病。
Neuroendocrinology. 2009;90(3):245-50. doi: 10.1159/000227807. Epub 2009 Jul 7.
9
Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators.心肌细胞肥大中Ca2+振荡频率解码:钙调神经磷酸酶/NFAT作为Ca2+信号整合器的作用
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2859-64. doi: 10.1073/pnas.0712316105. Epub 2008 Feb 19.
10
Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.醛固酮通过p38丝裂原活化蛋白激酶(MAPK)途径和盐皮质激素受体上调心室肌细胞中结缔组织生长因子基因的表达。
J Korean Med Sci. 2004 Dec;19(6):805-11. doi: 10.3346/jkms.2004.19.6.805.